Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.11604/pamj.2020.35.2.22945 http://scihub22266oqcxt.onion/10.11604/pamj.2020.35.2.22945 32528621!7266474!32528621     free     free     free       Pan+Afr+Med+J 2020 ; 35 (Suppl 2): 10 Nephropedia Template TP {{tp|p=32528621|t=2020. Thromboembolic risks in patients with COVID-19: major concern to consider in our management |pdf=|usr=}}{{32528621}} gab.com Text Thromboembolic risks in patients with COVID-19: major concern to consider in our management JO: Pan Afr Med J http://www.kidney.de/pget.php?&tw=1&pmid=32528621 #FOAvip COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many proposed drugs are under clinical trials. Considering the high incidence of thromboembolic events in critically ill patients with COVID-19, prevention of this disorder should be essential in order to reduce mortality in these patients. Twit Text FOAVip Thromboembolic risks in patients with COVID-19: major concern to consider in our management ????Pan Afr Med J http://www.kidney.de/pget.php?&tw=1&pmid=32528621 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32528621 #FOAvip English Wikipedia <ref>{{Cite pmid|32528621}}</ref> Thromboembolic risks in patients with COVID-19: major concern to consider in our management #MMPMID32528621 Temgoua MN; Kuate LM; Ngatchou W; Sibetcheu A; Toupendi ZN; Belobo G; Ossa A; Kingue S Pan Afr Med J 2020[]; 35 (Suppl 2): 10 PMID32528621show ga COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many proposed drugs are under clinical trials. Considering the high incidence of thromboembolic events in critically ill patients with COVID-19, prevention of this disorder should be essential in order to reduce mortality in these patients. |*Betacoronavirus[MESH] |*Pandemics[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications/*epidemiology/transmission[MESH] |Humans[MESH] |Incidence[MESH] |Pneumonia, Viral/*complications/*epidemiology/transmission[MESH] |SARS-CoV-2[MESH]Thromboembolic risks in patients with COVID-19: major concern to consi(epmc).pdf DeepDyve Pubget Overpricing